Overcoming multidrug resistance in gram-negative bacteria

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Increasing incidence of multidrug-resistant Gram-negative pathogens.
• Deficit in effective therapeutic agents for Gram-negative infections.
• Urgent need for novel therapeutic agents and approaches.

Purpose of the Study:

• To review current and emerging strategies for combating multidrug resistance in Gram-negative pathogens.
• To highlight the importance of genomic approaches and natural antibacterials.
• To emphasize the role of immunomodulation, vaccinology, and infection control.

Main Methods:

• Review of existing literature on antimicrobial resistance and novel therapeutic strategies.
• Exploration of genomic approaches for identifying new drug targets.
• Discussion of natural antibacterials, immunomodulation, and vaccinology.
• Emphasis on infection control and prudent antibiotic prescribing.

Main Results:

• Genomic approaches offer a multitude of novel targets for new classes of agents.
• Cationic antimicrobial peptides and bacteriophage are being pursued as therapeutic agents.
• Immunomodulation and vaccinology are increasingly useful in infectious disease management.
• Rigorous implementation of prescribing and infection control practices is crucial.

Conclusions:

• Novel therapeutic agents and approaches are essential to address multidrug resistance.
• A combination of strategies including genomics, natural products, and host-directed therapies is needed.
• Prudent use of therapies and robust infection control are imperative to avert a post-antimicrobial era.